These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies. Hoeller A, Ehrlich L, Golic M, Herse F, Perschel FH, Siwetz M, Henrich W, Dechend R, Huppertz B, Verlohren S. Hypertens Pregnancy; 2017 May; 36(2):151-160. PubMed ID: 28609172 [Abstract] [Full Text] [Related]
5. Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction. Kwiatkowski S, Dołegowska B, Kwiatkowska E, Rzepka R, Marczuk N, Loj B, Torbè A. J Perinat Med; 2017 Oct 26; 45(7):793-802. PubMed ID: 27865093 [Abstract] [Full Text] [Related]
6. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. Holme AM, Roland MC, Henriksen T, Michelsen TM. Am J Obstet Gynecol; 2016 Dec 26; 215(6):782.e1-782.e9. PubMed ID: 27503620 [Abstract] [Full Text] [Related]
7. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience. Müller A, Horvat V, Vulin M, Mandić S, Šerić V, Vidosavljević D. Med Glas (Zenica); 2019 Feb 01; 16(1):53-59. PubMed ID: 30680983 [Abstract] [Full Text] [Related]
10. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction. Herraiz I, Quezada MS, Rodriguez-Calvo J, Gómez-Montes E, Villalaín C, Galindo A. Ultrasound Obstet Gynecol; 2018 Nov 01; 52(5):631-638. PubMed ID: 28876491 [Abstract] [Full Text] [Related]
11. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction. Lorenz-Meyer LA, Frank L, Sroka D, Busjahn A, Henrich W, Verlohren S. Pregnancy Hypertens; 2022 Jun 01; 28():149-155. PubMed ID: 35453103 [Abstract] [Full Text] [Related]
12. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction. Nanjo S, Minami S, Mizoguchi M, Yamamoto M, Yahata T, Toujima S, Shiro M, Kobayashi A, Muragaki Y, Ino K. J Obstet Gynaecol Res; 2017 Dec 01; 43(12):1805-1814. PubMed ID: 28929598 [Abstract] [Full Text] [Related]
16. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies. Saleh L, Tahitu SIM, Danser AHJ, van den Meiracker AH, Visser W. Pregnancy Hypertens; 2018 Oct 01; 14():222-227. PubMed ID: 29678353 [Abstract] [Full Text] [Related]
17. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia. Triunfo S, Crovetto F, Crispi F, Rodriguez-Sureda V, Dominguez C, Nadal A, Peguero A, Gratacos E, Figueras F. Placenta; 2016 Jun 01; 42():44-50. PubMed ID: 27238713 [Abstract] [Full Text] [Related]
19. The sFlt-1/PlGF ratio values within the <38, 38-85 and >85 brackets as compared to perinatal outcomes. Bednarek-Jędrzejek M, Kwiatkowski S, Ksel-Hryciów J, Tousty P, Nurek K, Kwiatkowska E, Cymbaluk-Płoska A, Torbé A. J Perinat Med; 2019 Sep 25; 47(7):732-740. PubMed ID: 31339858 [Abstract] [Full Text] [Related]